Two subseries of nonquaternized (5a-10a) and quaternized derivatives (5b-10b) related to oxotremorine and oxotremorine-M were synthesized and tested. The agonist potency at the muscarinic receptor subtypes of the new compounds was estimated in three classical in vitro functional assays: M-1 rabbit vas deferens, M-2 guinea pig left atrium and M-3 guinea pig ileum. In addition, the occurrence of central muscarinic effects was evaluated as tremorigenic activity after intraperitoneal administration in mice. In in vitro tests a nonselective muscarinic activity was exhibited by all the derivatives with potencies values that, in some instances, surpassed those of the reference compounds (i.e. 8b). Functional selectivity was evidenced only for the oxotremorine-like derivative 9a, which behaved as a mixed M-3-agonist/M-1-antagonist (pD(2)-5.85; pA(2)=4.76, respectively). In in vivo tests nonquaternary compounds were able to evoke central muscarinic effects, with a potency order parallel to that observed in vitro. (C) 1999 Elsevier Science Ltd. All rights reserved.

Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M / C. Dallanoce, P. Conti, M. De Amici, C. De Micheli, E. Barocelli, M. Chiavarini, V. Ballabeni, S. Bertoni, M. Impicciatore. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 7:8(1999), pp. 1539-1547.

Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M

C. Dallanoce
Primo
;
P. Conti
Secondo
;
M. De Amici;C. De Micheli;
1999

Abstract

Two subseries of nonquaternized (5a-10a) and quaternized derivatives (5b-10b) related to oxotremorine and oxotremorine-M were synthesized and tested. The agonist potency at the muscarinic receptor subtypes of the new compounds was estimated in three classical in vitro functional assays: M-1 rabbit vas deferens, M-2 guinea pig left atrium and M-3 guinea pig ileum. In addition, the occurrence of central muscarinic effects was evaluated as tremorigenic activity after intraperitoneal administration in mice. In in vitro tests a nonselective muscarinic activity was exhibited by all the derivatives with potencies values that, in some instances, surpassed those of the reference compounds (i.e. 8b). Functional selectivity was evidenced only for the oxotremorine-like derivative 9a, which behaved as a mixed M-3-agonist/M-1-antagonist (pD(2)-5.85; pA(2)=4.76, respectively). In in vivo tests nonquaternary compounds were able to evoke central muscarinic effects, with a potency order parallel to that observed in vitro. (C) 1999 Elsevier Science Ltd. All rights reserved.
Iileum; Left atrium; Muscarinic agonists; Oxotremorine; Oxotremorine-M; Synthesis; Tremorigenic activity; Vas deferens
Settore CHIM/08 - Chimica Farmaceutica
1999
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/183355
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 42
social impact